93 related articles for article (PubMed ID: 18622748)
1. KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2.
Mu Z; Wang H; Zhang J; Li Q; Wang L; Guo X
Sci China C Life Sci; 2008 Jul; 51(7):648-54. PubMed ID: 18622748
[TBL] [Abstract][Full Text] [Related]
2. [Adenovirus-mediated overexpression of KAI1 suppresses sphingosine kinase activation and metastasis of pancreatic carcinoma cells].
Guo XZ; Zhang WW; Wang LS; Lu ZZ; Wang H; Xu JH; Tian H
Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):752-4. PubMed ID: 17166452
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer.
Chai J; Du L; Ju J; Ma C; Shen Z; Yang X; Liang L; Ni Q; Sun M
Mol Med Rep; 2017 Apr; 15(4):1527-1532. PubMed ID: 28260006
[TBL] [Abstract][Full Text] [Related]
5. KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity.
Liu X; Guo XZ; Zhang WW; Lu ZZ; Zhang QW; Duan HF; Wang LS
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):201-8. PubMed ID: 21459729
[TBL] [Abstract][Full Text] [Related]
6. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus inhibits the expression of CD82 through hypermethylation of its promoter in hepatoma cells.
Yu G; Bing Y; Li W; Xia L; Liu Z
Mol Med Rep; 2014 Nov; 10(5):2580-6. PubMed ID: 25119390
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
[TBL] [Abstract][Full Text] [Related]
10. miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.
Mine M; Yamaguchi K; Sugiura T; Chigita S; Yoshihama N; Yoshihama R; Hiyake N; Kobayashi Y; Mori Y
PLoS One; 2015; 10(7):e0131350. PubMed ID: 26132195
[TBL] [Abstract][Full Text] [Related]
11. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
Dai W; Wang C; Wang F; Wang Y; Shen M; Chen K; Cheng P; Zhang Y; Yang J; Zhu R; Zhang H; Li J; Zheng Y; Lu J; Zhou Y; Xu L; Guo C
Biochem Biophys Res Commun; 2014 Apr; 446(2):541-8. PubMed ID: 24613834
[TBL] [Abstract][Full Text] [Related]
12. [Sphingosine kinase regulates hepatocyte growth factor-induced migration of endothelial cells].
Yi J; Lu ZZ; Duan HF; Gai LY; Wang LS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):230-4. PubMed ID: 21162249
[TBL] [Abstract][Full Text] [Related]
13. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
14. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical value of KAI1/CD82 in carcinoma of larynx].
Shu Y; Chen H; Tan Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(23):1065-7. PubMed ID: 16494006
[TBL] [Abstract][Full Text] [Related]
17. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer.
Christgen M; Bruchhardt H; Ballmaier M; Krech T; Länger F; Kreipe H; Lehmann U
Int J Cancer; 2008 Nov; 123(10):2239-46. PubMed ID: 18712725
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.
Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA
PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627
[TBL] [Abstract][Full Text] [Related]
19. The role of the metastasis suppressor gene KAI1 in melanoma angiogenesis.
Tang Y; Bhandaru M; Cheng Y; Lu J; Li G; Ong CJ
Pigment Cell Melanoma Res; 2015 Nov; 28(6):696-706. PubMed ID: 26199094
[TBL] [Abstract][Full Text] [Related]
20. [Effect of metastasis suppressor gene KAI1 on adhesion of hepatocellular carcinoma cell line MHCC97-H].
Yu Y; Han DE; Liu W
Ai Zheng; 2007 May; 26(5):498-503. PubMed ID: 17672940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
